XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
132 hedge funds and large institutions have $826M invested in Intersect ENT, Inc in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $644K
Holders
132
Holding in Top 10
2
Calls
–
Puts
$644K
Top Buyers
| 1 | +$10.2M | |
| 2 | +$9.94M | |
| 3 | +$7.74M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
+$6.19M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$5.21M |
Top Sellers
| 1 | -$36M | |
| 2 | -$28M | |
| 3 | -$13.9M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$10.9M |
| 5 |
RA
Ramius Advisors
New York
|
-$7.33M |
